Childrens Chewable Acetaminophen

Description

The drug is a white to off-white, crystalline powder. Its chemical name is insert chemical name here. The molecular formula is insert molecular formula here, and it has a molecular weight of insert molecular weight here. Inactive ingredients include insert inactive ingredients here.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains and for the temporary reduction of fever. There are no known teratogenic or nonteratogenic effects associated with this medication.

Dosage and Administration

Patients should chew the tablets thoroughly before swallowing. The dosage should be determined according to the provided dosage table or as directed by a healthcare professional. When possible, dosing should be based on the patient's weight; if weight is not available, age may be used as a guide.

The recommended dosing intervals are every 4 hours as needed, with a maximum of 5 doses within a 24-hour period. Administration should only occur under adult supervision, and it is imperative that the maximum dose indicated in the dosage table is not exceeded.

Dosage Table:

Weight (lb):

• Under 24: Consult a doctor

• 24-35: 2 tablets

• 36-47: 3 tablets

• 48-59: 4 tablets

• 60-71: 5 tablets

• 72-95: 6 tablets

Age:

• Under 2: Consult a doctor

• 2-3: 2 tablets

• 4-5: 3 tablets

• 6-8: 4 tablets

• 9-10: 5 tablets

• 11: 6 tablets

Healthcare professionals should ensure that patients adhere to these guidelines to promote safe and effective use of the medication.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, is prohibited. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• This product should not be used in patients with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage if the maximum daily dosage is exceeded. Specifically, healthcare professionals should advise caregivers that no more than five doses should be administered within a 24-hour period. Additionally, caution is warranted when this product is used concurrently with other medications containing acetaminophen, as this may further increase the risk of liver injury.

Acetaminophen may also trigger severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

Healthcare providers should inquire about the patient's medical history, particularly regarding liver disease, before recommending this product. Furthermore, it is advisable to consult with a doctor or pharmacist if the child is concurrently taking warfarin, a blood-thinning medication, to avoid potential interactions.

In cases of suspected overdose, immediate medical attention is essential. Caregivers should be instructed to contact a Poison Control Center or seek emergency medical help without delay, as prompt intervention is critical for both adults and children, even in the absence of overt symptoms.

Patients should be advised to discontinue use and consult a healthcare professional if any of the following occur: worsening pain lasting more than five days, fever that persists or worsens beyond three days, the emergence of new symptoms, or the presence of redness or swelling. These signs may indicate a serious underlying condition that requires further evaluation.

Side Effects

Severe adverse reactions associated with this product include the potential for severe liver damage, particularly in patients who exceed the maximum daily dosage of five doses within a 24-hour period or who concurrently use other medications containing acetaminophen. Patients should be advised of the risk of severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use and seek immediate medical assistance.

Patients should not use this product in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. It is also contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients present in the formulation.

Prior to use, it is essential for patients to consult a healthcare professional if they have a history of liver disease. Additionally, patients taking the anticoagulant warfarin should seek advice from a doctor or pharmacist before using this product.

Patients are advised to discontinue use and consult a healthcare provider if pain worsens or persists beyond five days, if fever intensifies or lasts more than three days, if new symptoms arise, or if there is any redness or swelling, as these may indicate a serious underlying condition.

In cases of overdose, immediate medical attention is crucial. Patients and caregivers should contact a Poison Control Center or seek medical help without delay, even if no signs or symptoms are initially apparent, as prompt intervention is critical for both adults and children.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. Co-administration may lead to an increased risk of acetaminophen-related toxicity. If there is uncertainty regarding the presence of acetaminophen in other medications, it is advisable to seek guidance from a healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Chewable Acetaminophen (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a doctor before use. For children aged 2 to 3 years, the recommended dosage is 2 tablets; for those aged 4 to 5 years, 3 tablets; for 6 to 8 years, 4 tablets; for 9 to 10 years, 5 tablets; and for 11 years, 6 tablets. Dosing should occur every 4 hours as needed, with a maximum of 5 doses in a 24-hour period. It is preferable to use weight for dosing; if weight is not available, age may be used. Administration should only occur under adult supervision.

Caution is advised due to the risk of severe liver damage if more than 5 doses are taken in 24 hours or if used concurrently with other medications containing acetaminophen. An allergy alert is warranted, as acetaminophen may cause severe skin reactions, including skin reddening, blisters, and rash. If any skin reaction occurs, use should be discontinued immediately, and medical assistance should be sought. Prior to use, consultation with a doctor is recommended if the child has liver disease or is taking the blood-thinning medication warfarin.

Parents and caregivers should discontinue use and consult a doctor if the child's pain worsens or persists beyond 5 days, if fever worsens or lasts more than 3 days, if new symptoms arise, or if redness or swelling is observed. In the event of an overdose, immediate medical help or contact with a Poison Control Center is essential, as prompt attention is critical for both children and adults, even if no signs or symptoms are evident.

Geriatric Use

Elderly patients should be aware that this product does not contain specific directions or complete warnings tailored for adults. Therefore, it is crucial that this product is administered only under adult supervision to ensure safety and proper usage. Healthcare providers should exercise caution when considering the use of this product in geriatric patients, as the lack of comprehensive guidance may pose risks. Monitoring for any adverse effects or complications is recommended during the administration of this product in the elderly population.

Pregnancy

There is no specific information available regarding the use of Children's Chewable Acetaminophen during pregnancy. As such, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

Nursing mothers should consult a doctor before using this product. There is a potential for excretion of acetaminophen in breast milk. Caution is advised when administering this medication to nursing mothers due to the potential risk to the infant.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if they have a history of liver disease. It is essential to assess liver function and consider potential adjustments in dosage or monitoring requirements based on the severity of the impairment. Close monitoring of liver function tests may be warranted to ensure safety and efficacy in this patient population.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Quick medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the lack of immediate symptoms does not preclude the potential for serious health consequences. Therefore, it is essential to monitor the patient closely and provide appropriate interventions as necessary. Prompt evaluation and management can significantly impact the outcome in cases of overdose.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

Postmarketing experience has identified that acetaminophen may be associated with severe skin reactions. Reports indicate that symptoms can include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use immediately and seek medical assistance.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose, as prompt medical attention is crucial for both adults and children, even if no signs or symptoms are apparent.

Patients should be informed not to use this medication in conjunction with any other drug that contains acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in another medication, patients are encouraged to consult with a doctor or pharmacist.

It is important to instruct patients not to administer this product to children who are allergic to acetaminophen or any of the inactive ingredients contained within the formulation.

Patients should be advised to discontinue use and consult a doctor if pain worsens or persists for more than 5 days, or if fever intensifies or lasts longer than 3 days. Additionally, they should be informed to stop use and seek medical advice if new symptoms arise or if there is any redness or swelling, as these may indicate a serious condition.

Healthcare providers should recommend that patients consult a doctor prior to use if their child has liver disease. Furthermore, patients should be encouraged to speak with a doctor or pharmacist before using this medication if their child is currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in a configuration that includes an NDC number for identification. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and must be kept in a location that avoids high humidity. The container should remain tightly closed to maintain product integrity. Additionally, the product should not be used if the imprinted seal under the cap is missing or broken, as this may indicate compromised safety or efficacy.

Additional Clinical Information

Patients should be advised that the medication is administered orally in the form of chewable tablets, which must be thoroughly chewed before swallowing. The recommended dosing frequency is every 4 hours as needed, with a maximum of 5 doses within a 24-hour period. Administration should occur under adult supervision.

Clinicians should counsel patients to consult a doctor prior to use if the child has liver disease or is taking the anticoagulant warfarin. Additionally, patients should be instructed to discontinue use and seek medical advice if pain worsens or persists beyond 5 days, if fever worsens or lasts more than 3 days, if new symptoms arise, or if there is any redness or swelling.

Drug Information (PDF)

This file contains official product information for Childrens Chewable Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)